Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Oktober 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present on Liposome Delivery Systems at 2014 American Association of Pharmaceutical Scientists Annual Meeting

EWING, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
28. Oktober 2014 10:48 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
27. Oktober 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Phase 3 Clinical Study of CPX-351 Achieved Target Enrollment in High Risk (Secondary) Acute Myeloid Leukemia

EWING, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
23. Oktober 2014 07:00 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public Offering of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
17. Oktober 2014 12:57 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock

EWING, N.J., Oct. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
19. September 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference

EWING, N.J., Sept. 19, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
17. September 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell on September 17, 2014

EWING, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
15. September 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Publication of Preclinical Data for CPX-351 in Acute Lymphoblastic Leukemia Models

EWING, N.J., Sept. 15, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
03. September 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board

EWING, N.J., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
02. September 2014 08:30 ET | Quelle: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference

EWING, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...

Nächste Seite